Biotech Values

[ghmm]

Webcasts/Company Disclosure:

I think its a hairy line about what is material and not so I'd rather have things all be webcasts (especially breakouts as Brad Loncar and others suggested). This would help to level the playing field. I once got in a little heated discussion about a company changing its trial (The size was changed and I believe an end point slightly modified but not certain of my recollection on that part) and selectively disclosing in it. It wasn't my intent to make it a heated discussion but the other party got defensive when I said I thought it was material. I don't want to say who it was publicly but needless to say the company doesn't do a good job of making all that is said in meetings available to all shareholders.